Brazil Periodontal Therapeutics Market Analysis

Brazil Periodontal Therapeutics Market Executive Summary

Brazil Periodontal Therapeutics Market is at around $21.8 Mn in 2023 and is projected to reach $37.9 Mn in 2030, exhibiting a CAGR of 8.2% during the forecast period.

Periodontal disease, often known as gum disease, is a dangerous dental ailment that is associated with gum inflammation and infection. Periodontitis is a common condition often caused by inadequate oral hygiene that can be largely avoided with the use of therapeutic, non-surgical, or surgical treatment approaches. Treating periodontitis with antibiotics alone is known as periodontal therapy, a relatively new yet successful treatment strategy that is becoming more and more popular among patients and dentists. Amoxicillin, doxycycline, and metronidazole are common antibiotics used in periodontal therapy. As adjuvant therapy, a variety of mouthwashes and rinses containing antimicrobial substances such as hydrogen peroxide, chlorhexidine, and essential oils can reduce gingival inflammation and plaque.

The Brazil periodontal market exhibits significant prevalence rates ranging from 34.4% to 63.8% in individuals aged 35 years or older, influenced by demographic factors and healthcare expenses. With a diverse population and varying socio-economic backgrounds, the prevalence of periodontal conditions like gingivitis and periodontitis is notable. Demographic factors such as age, socio-economic status, and access to dental care play crucial roles in shaping this market. Healthcare expenses related to periodontal treatment contribute to the market dynamics, impacting affordability and treatment choices among different segments of the population. Therefore, the market is driven by significant factors like Rising Prevalence of periodontitis, Technological Advancements, and Emphasis on Preventive Oral Care. However, Limited insurance coverage for periodontal treatments, Side Effects and Complications, and High Costs restrict the growth and potential of the market.

OraVu®, which is a dental technology company dealing in dental endoscopy solutions, launched a complete micro-endoscope system called DeVA-1® Dental Vision Assistant.

Market Dynamics

Market Growth Drivers

Rising Prevalence of Periodontitis: Periodontal disease, if left untreated, can lead to significant issues including tooth loss and other major health problems. Early treatment is crucial to prevent chronic inflammation, which is known to increase the risk of diabetes, insulin resistance, and impaired glucose tolerance. Despite the availability of treatments, the prevalence of periodontal disease remains high ranging from 34.4% to 63.8%, affecting a large segment of the population. This issue is exacerbated by growing urbanization and changing living conditions, which contribute to the rise in oral health problems.

Technological Advancements: The diagnosis, treatment, and management of periodontal disease have all been greatly enhanced by technological developments in dentistry. Periodontists are now able to create accurate three-dimensional (3D) models of their patients' mouths because of digital dentistry, which also includes improved imaging techniques. These models improve treatment accuracy and communication between dental practitioners by making operations like dental implants easier to design. Patient results increase as a result, and dental care becomes more efficient and productive.

Emphasis on Preventive Oral Care: The emphasis on preventive oral care, patient education, and early intervention strategies in dentistry underscores the importance of periodontal maintenance therapies, oral hygiene instructions, and professional prophylaxis services in preventing periodontal diseases and preserving periodontal health. Dental professionals advocate for regular dental check-ups, periodontal screenings, and patient-centered care plans tailored to individual risk factors, oral health behaviors, and treatment needs to mitigate periodontal disease progression and prevent complications.

Market Restraints

Limited insurance coverage for periodontal treatments: Brazil, insufficient insurance coverage 30% for periodontal treatments acts as a barrier to market expansion. Public health insurance often provides limited coverage for dental procedures, leaving many individuals reliant on private insurance with high premiums and restrictive coverage for advanced periodontal care. This financial burden hinders widespread adoption of comprehensive periodontal services, limiting market demand and growth opportunities.

Side Effects and Complications Periodontal market faces challenges due to heightened concerns regarding aesthetic outcomes following treatments such as dental implants and periodontal plastic surgery. Patients prioritize not only functional restoration but also aesthetic results, with potential side effects like uneven gum lines or implant failure influencing treatment acceptance and patient satisfaction. These concerns can deter individuals from seeking or completing necessary periodontal procedures, impacting market growth.

High cost: The dental methodology is often viewed as costlier, as more specialized dental care requires a highly trained and modern dental team to ensure high-quality service. Advanced dental and periodontal procedures become prohibitively expensive for the average citizen. Additionally, government mandates and interventions further escalate the cost of care. According to a recent study, over 40% of patients delay or avoid necessary periodontal treatments due to high costs. Consequently, expensive surgery has become a significant issue for periodontal service providers, restraining market growth.

Regulatory Landscape and Reimbursement scenario

The regulatory landscape governing the periodontics market is robust and evolving. Regulatory oversight ensures compliance with standards set by the Brazilian Health Regulatory Agency (ANVISA), covering aspects from product registration to clinical practices. This framework aims to ensure the safety, efficacy, and quality of periodontal treatments and products, fostering innovation while safeguarding public health. Market players navigate stringent requirements for product approval and advertising, adhering to guidelines that promote ethical practices and patient welfare. Continuous updates and adherence to regulatory changes are pivotal for stakeholders in the Brazilian periodontics market to maintain competitiveness and uphold industry standards.

Effective reimbursement mechanisms ensure that periodontal treatments, including scaling and root planning, periodontal surgery, and maintenance therapy, are financially viable for patients. The market's dynamics are shaped by public and private healthcare systems, with varying coverage levels and reimbursement rates influencing treatment choices and access to specialized care. Regulatory frameworks and insurance policies continually evolve, impacting both practitioners and patients in their approach to managing periodontal health and overall oral care expenses within Brazil's healthcare landscape.

Competitive Landscape

Key Players

Here are some of the major key players in Brazil Periodontal Therapeutics Market:

• Tokyo Chemical Industry Co., Ltd.
• Bausch Health Companies Inc.
• Melinta Therapeutics LLC
• Pfizer Inc.
• Lupin Ltd
• Teva Pharmaceuticals USA, Inc.
• Sun Pharmaceutical Industries Ltd.
• Cipla, Inc.
• Chartwell Pharmaceuticals LLC.
• ASA Dental S.p.A.
• Steris-Hu-Friedy
• Carl Martin GmBH